UPLC-MS/MS quantification of quercetin in plasma and urine following parenteral administration
Abstract Background Study of pharmacokinetics of quercetin (Qu) and its derivatives after infusion is required in order to better understand mechanisms of therapeutic action of the formulation and development the strategic approaches to treat the underlying disease and pathologically similar syndrom...
Main Authors: | Igor A. Zupanets, Yuri V. Pidpruzhnykov, Valerii E. Sabko, Natalia P. Bezugla, Sergii K. Shebeko |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2019-01-01
|
Series: | Clinical Phytoscience |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40816-019-0107-1 |
Similar Items
-
Establishment and validation of a UPLC-MS/MS bioassay for the quantification of infigratinib in rat plasma
by: Xuegu Xu, et al.
Published: (2022-07-01) -
Development of an UPLC-MS/MS method for quantitative analysis of abexinostat levels in rat plasma and application of pharmacokinetics
by: Yige Yu, et al.
Published: (2024-02-01) -
UPLC–MS/MS for the determination of azilsartan in beagle dog plasma and its application in a pharmacokinetics study
by: Cheng Gong, et al.
Published: (2015-06-01) -
Determination of oleandrin and adynerin in rat plasma by UPLC–MS/MS and their pharmacokinetic study
by: Meiling Zhang, et al.
Published: (2022-12-01) -
An Ultra-Performance Liquid Chromatography–Tandem Mass Spectrometry (UPLC–MS/MS) Method for Qualifying DAPB in Rat Plasma and Application to Pharmacokinetic Studies
by: Bei Qin, et al.
Published: (2024-01-01)